APA

Ferraro D., Goldstein D., O'Connell R. L., Zalcberg J. R., Sjoquist K. M., Tebbutt N. C., Grimison P., McLachlan S., Lipton L. L., Vasey P., Gebski V. J., Aiken C., Cronk M., Ng S., Karapetis C. S. & Shannon J. (20170606). TACTIC: a multicentre, open-label, single-arm phase II trial of panitumumab, cisplatin, and gemcitabine in biliary tract cancer. : Cancer chemotherapy and pharmacology.

Chicago

Ferraro D, Goldstein D, O'Connell R L, Zalcberg J R, Sjoquist K M, Tebbutt N C, Grimison P, McLachlan S, Lipton L L, Vasey P, Gebski V J, Aiken C, Cronk M, Ng S, Karapetis C S and Shannon J. 20170606. TACTIC: a multicentre, open-label, single-arm phase II trial of panitumumab, cisplatin, and gemcitabine in biliary tract cancer. : Cancer chemotherapy and pharmacology.

Harvard

Ferraro D., Goldstein D., O'Connell R. L., Zalcberg J. R., Sjoquist K. M., Tebbutt N. C., Grimison P., McLachlan S., Lipton L. L., Vasey P., Gebski V. J., Aiken C., Cronk M., Ng S., Karapetis C. S. and Shannon J. (20170606). TACTIC: a multicentre, open-label, single-arm phase II trial of panitumumab, cisplatin, and gemcitabine in biliary tract cancer. : Cancer chemotherapy and pharmacology.

MLA

Ferraro D, Goldstein D, O'Connell R L, Zalcberg J R, Sjoquist K M, Tebbutt N C, Grimison P, McLachlan S, Lipton L L, Vasey P, Gebski V J, Aiken C, Cronk M, Ng S, Karapetis C S and Shannon J. TACTIC: a multicentre, open-label, single-arm phase II trial of panitumumab, cisplatin, and gemcitabine in biliary tract cancer. : Cancer chemotherapy and pharmacology. 20170606.